The ACT Government announced this week that pharmacists in the ACT will be able to expand their scope of practice.
This comes following successful campaigning by the Pharmaceutical Society of Australia (PSA) to expand the scope of practice for pharmacists.
Under the legislative update, pharmacists in the ACT are now authorised to administer medicines for injection, including Long-Acting Injectable Buprenorphine (LAIB).
PSA’s ACT Branch President Olivia Collenette says this landmark change will enhance patient access to vital injectable medications.
“We have long championed the expansion of pharmacist scope of practice and, while there is still a long way to go, this is a significant step,” says Ms Collenette.
“We are thrilled that our advocacy on this particular issue has borne fruit, signalling a brighter future for pharmacy and reinforcing our commitment to advancing patient-centred care.”
To help pharmacists in this expanded scope of practice, the PSA offers comprehensive training on administering medicines by injection.
Pharmacists are encouraged to access these resources to ensure they are equipped with the necessary knowledge and skills to provide optimal care.
“PSA encourages all pharmacists in the ACT to familiarise themselves with the updated regulations and embrace this progressive expansion of their professional capabilities,” says Ms Collenette.
“By staying informed and ensuring adherence to best practices, pharmacists will continue to play a pivotal role in enhancing patient outcomes and promoting public health.”
For more information, visit: health.act.gov.au/health-professionals/pharmaceutical-services/pharmacist-vaccinations-and-injectables.